Grade: Pharmaceutical Grade

Factory Location: Xiamen, Fujian

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East

Monthly Production Capacity: 1000kg

Packaging Information: 25kg/drum 1kg/bottle

Delivery Lead Time: 7 days after payment

Sample Provided: yes

Payment Terms: L/L

Product Information

 

Product name	Ropivacaine Hydrochloride / Ropivacaine HCL
CAS No.	132112-35-7
Molecular Formula	C17H26N2O·HCl·
Molecular Weight	328.88
Quality Standard	98% up by HPLC
Appearance	White powder

 

COA of Ropivacaine Hydrochloride

 

Items	Specifications	Results
Appearance	White Powder	Complies
Assay (HPLC)	98%min	99.8%
Odor	Characteristic	Complies
Sieve analysis	100% pass 80 mesh	Complies
Heavy Metal	<10ppm	Complies
As	< 0.1ppm	0.05ppm
Pb	< 0.1ppm	0.05ppm
Cd	< 0.1ppm	0.05ppm
Residual solvents	<100ppm	Complies
Residual pesticide	Negative	Complies
Total Plate Count	< 1000 cfu/g	Complies
Yeast&Mold	< 100 cfu/g	Complies
E.Coli	Negative	Complies
Salmonella	Negative	Complies
Conclusion	Meet the specification of standards

 

Usage

 

Function of Ropivacaine Hydrochloride

 

Since it was discovered that long-acting local anesthetics can induce cardiac arrest, people have been seeking alternative medicines that are less fat-soluble and safer. Ropivacaine is such a new type of long-acting amide local anesthetic, which has a long duration of action, and has anesthetic and analgesic effects. Its pharmacological characteristics are low cardiotoxicity, obvious separation of sensory block and motor block, and peripheral vasoconstriction. Therefore, the drug is especially suitable for postoperative analgesia and obstetric anesthesia.

Compared with traditional local anesthetics, Ropivacaine HCL has the following advantages:

1. Curative effect: The action time of ropivacaine is significantly longer than other long-acting local anesthetics, and the action time of subcutaneous infiltration anesthesia is 2 to 3 times longer than that of bupivacaine of the same concentration.

2. Unique curative effect-the sensory-motor block separation of ropivacaine is much greater than that of bupivacaine, and the clearance rate is higher, making it more suitable for analgesia.

3. Strong controllability-the anesthetic effect of ropivacaine is dose-dependent, which means that the degree of sensory and motor block produced by ropivacaine is predictable and controllable.

4. Low toxic and side effects-Ropivacaine does not have the disadvantage of greater cardiotoxicity of general long-acting local anesthetics. Cardiotoxicity is rarely caused by this product, and the fetus has good tolerance to this product.